My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
 
Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA
March 2009
Vol. 19 No. 3
Patient Care and Science
Drug Approvals, Recalls, Adverse Events Update

IDSA offers two e-mail services to help members stay informed of updates from the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA). Recent alerts have included:

IDSA members can sign up for these alerts online. (You must be logged in to have access to this link.)

In addition, FDA has launched a new hepatitis list serve. This new e-mail list will provide updates on safety and regulatory issues related to hepatitis B and C products. The e-mail list is intended to provide one source for FDA information on a variety of topics related to hepatitis B and C, including proposed regulatory guidances, opportunity to comment, and notices of upcoming public meetings. Sign up on FDA’s web page. (Please note that this page does not mention the hepatitis list serve. However, users receive notification that they have subscribed to the hepatitis list serve after they enter an e-mail address.)


Is Your Facility Experiencing Antibiotic Shortages?
Report these to FDA and IDSA.
How useful is this article?

< Previous Article | Next Article >

Post a comment

Your name:

Your comment:


Top Stories
New Influenza Guidelines Released
CDC Calls for Stepped-up Efforts against Carbapenem-resistant Bugs
Long-awaited FDA Guidance on CAP Drugs Released
IDSA Journal Club
Patient Care and Science
EIN: Better Testing for C. difficile
Drug Approvals, Recalls, Adverse Events Update
Practice Management
Medical Societies Raise Concerns About Medicare Audit Program
Global ID
New HIV/TB Figures Call for Increased Funding, ID Center Says
Policy and Advocacy
IDSA Responds to Supermarketsí Free Antibiotics Promotions
Forum Makes the Case for Medicare Coverage of Home Infusion Therapy
Deadline Extended for Public Input on Lyme Disease Guidelines
Your Colleagues
Welcome New IDSA Members!

IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add 'idsa@idsociety.org' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.